PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
March 15, 2012 | ISSUE NUMBER 242 VOL 8

Companies
AZ's Battle Over Seroquel
AstraZeneca has resorted to suing FDA in a bid to stop it from approving generic competition to Seroquel, the company's blockbuster anti-depressant, before December 2012. But is it a mark of desperation, asks Ana Nicholls ...Read More

Advertisement
Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
On-Demand Webcast
Click here

Comment
Patient Assistance Programs: Are They Still Relevant?
A shifting landscape of government fiscal pressures, economic decline and the erratic pace of health reform is putting the Patient Assistance Program (PAP) model under intense scrutiny. Using the old rubric that no good deed should go unpunished, a growing list of stakeholders is posing the pregnant question: are PAPs still relevant? ...Read More

Healthcare Economics
Cat Fight on Co-Pay Offsets
The tussle between pharmacy benefit managers [PBMs] and brand name drug manufacturers over the use of co-pay and discount cards to limit out-of-pocket costs for patients has caught fire, moving from rhetoric to preemptive action and now to litigation. Indeed, it is fast becoming the topic du jour for the US industry, overshadowing Obamacare in terms of its potential to disrupt the once staid relationship between manufacturers, service providers, and payers ...Read More

Strategy
Novartis: Taking the LEAD in BRIC
With growth as its guiding light, Novartis has big plans for the emerging markets. Pharm Exec sits down with CEO Joe Jimenez to understand what the company is doing to beat the competition
...Read More

Advertisement
Utilization of Rasch Measurement Models for Assessing Validity: A Mixed Methods Approach
On-Demand Webcast
Click here

// Catalent Pharma Solutions, Inc. (Somerset, NJ) announced the appointment of Jeremie Trochu to the newly created position of Vice President, Commercial Excellence. // The Board of Directors of the CMR Institute (Roanoke, Va.) announced Michelle O' Connor as President and CEO. // Gloria Gibbons, President of EMEA, AP, Latina, at Ogilvy CommonHealth Worldwide (Parisppany, NJ) has been elected Chair of the Health Communications Council of the European Association of Communications Agencies (EACA).

March 22-23: 5th Annual Forum on Clinical Trial Management Systems
Philadelphia, PA


April 26–27: 11th Annual Patient Adherence Forum
Philadelphia, PA


May 7–8: Bio/Pharma Forum on Regulatory Policy
Washington, DC



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook


Survey
What do you see as the chief obstacle to achieving growth in the emerging markers?

Click To Vote
 
Quick Links

Highlights from the Leerink Swann Healthcare Conference

Brad Sitler on Missed Opportunities in Data Analytics

FDA Guidance Agenda 2012


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive